Research Paper Volume 15, Issue 11 pp 5215—5227
PUS1 is a novel biomarker for evaluating malignancy of human renal cell carcinoma
Figure 3. Construction of a predictive nomogram. (A, B) Univariate (A) and multivariate (B) Cox regression analyses were performed in renal cancer. (C) The nomogram gives 1-, 3- and 5-year overall survival in renal cancer. (D) The survival time of renal cancer dataset is displayed.